Author

Gary L. Craig

Observed names: Craig, Gary, Craig, Gary L., G Craig, G. Craig, G. L. Craig, Gary Craig

Institution: Arthritis Northwest

Observed institutions: McMaster University Medical Centre, Arthritis Northwest, St. Joseph’s Healthcare Hamilton, McMaster University

OpenAlex ID: A5058267822

Salmon calcitonin nasal spray in the prevention of corticosteroid- induced osteoporosis

1997 · J. D. Adachi, W. G. Bensen, et al. · Rheumatology · 106

Treatment Persistence and Clinical Outcomes of Tumor Necrosis Factor Inhibitor Cycling or Switching to a New Mechanism of Action Therapy: Real-world Observational Study of Rheumatoid Arthritis Patients in the United States with Prior Tumor Necrosis Factor Inhibitor Therapy

2017 · Wenhui Wei, Keith Knapp, et al. · Advances in Therapy · 63

Gold induced thrombocytopenia: 12 cases and a review of the literature

1987 · Jonathan D. Adachi, William G. Bensen, et al. · Seminars in Arthritis and Rheumatism · 48

Epidemiology and clinical characteristics of interstitial lung disease in patients with rheumatoid arthritis from the JointMan database

2023 · Joe Zhuo, Sonie Lama, et al. · Scientific Reports · 24

Antirheumatic Drugs

1980 · Gary L. Craig, W. Watson Buchanan · Drugs · 24

Intermittent Cyclic Therapy with Etidronate Prevents Corticosteroid-induced Bone Loss: Two Years of Follow-up

1996 · R. J. Sebaldt, J. D. Adachi, et al. · Scandinavian Journal of Rheumatology · 21

Epigenome association study for DNA methylation biomarkers in buccal and monocyte cells for female rheumatoid arthritis

2021 · Gary Craig, Howard Kenney, et al. · Scientific Reports · 20

Treatment Patterns, Disease Burden, and Outcomes in Patients with Giant Cell Arteritis and Polymyalgia Rheumatica: A Real-World, Electronic Health Record-Based Study of Patients in Clinical Practice

2021 · Gary Craig, Keith Knapp, et al. · Rheumatology and Therapy · 17

Op0035 Examination of Interstitial Lung Disease in Patients With Rheumatoid Arthritis – Prevalence, Time to Onset, and Clinical Characteristics

2020 · J. Zhuo, Q. Zhang, et al. · Annals of the Rheumatic Diseases · 6

AB0290 United States Rheumatologists Who Consistently Measure Disease Activity in Rheumatoid Arthritis (RA) are Achieving Low Disease Activity (LDA) and Remission (R)

2014 · S. Schwartzman, G. Craig, et al. · Annals of the Rheumatic Diseases · 1

Thu0294 Treatment Patterns, Disease Burden and Outcomes in Patients With Giant Cell Arteritis and Polymyalgia Rheumatica

2019 · Gary Craig, Keith Knapp, et al. · Annals of the Rheumatic Diseases

SAT0133 Prevalence of type 2 diabetes and evaluation of patient characteristics among patients with and without ra from community rheumatologyclinics

2018 · E. Alemao, L. Ferri, et al. · Annals of the Rheumatic Diseases

FRI0232 Treatment effects of abatacept and anti-tnf in patients with ra with poor prognostic factors: data from community rheumatology clinics

2017 · E Alemao, K Knapp, et al. · Annals of the Rheumatic Diseases

FRI0233 Real-World Treatment Persistence and Clinical Outcomes of TNFI Cycling vs Switching To New Mechanism-of-Action Dmards among Patients with Rheumatoid Arthritis in The United States

2016 · W. Wei, K. Knapp, et al. · Annals of the Rheumatic Diseases

DISE Summary Report (1992)

1994 · Vaughn T. Combs, Gary L. Craig, et al. · Defense Technical Information Center (DTIC)

Works count: 17

Citation count: 330

H-index: 8

I10-index: 8